These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21751919)

  • 21. Alopecia and dalteparin: a previously unreported association.
    Barnes C; Deidun D; Hynes K; Monagle P
    Blood; 2000 Aug; 96(4):1618-9. PubMed ID: 10979669
    [No Abstract]   [Full Text] [Related]  

  • 22. Heparin-induced thrombocytopenia without thrombocytopenia in a patient with essential thrombocythemia.
    Houston DS
    Am J Hematol; 2000 Dec; 65(4):331-2. PubMed ID: 11074573
    [No Abstract]   [Full Text] [Related]  

  • 23. PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan.
    Cook D; Meade M; Guyatt G; Walter SD; Heels-Ansdell D; Geerts W; Warkentin TE; Cooper DJ; Zytaruk N; Vallance S; Berwanger O; Rocha M; Qushmaq I; Crowther M
    J Crit Care; 2011 Apr; 26(2):223.e1-9. PubMed ID: 21482348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The landscape of thromboprophylaxis utilization in critically ill children: sparse and variable.
    Gist KM; Chima RS
    Crit Care Med; 2014 May; 42(5):1317-8. PubMed ID: 24736356
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin.
    Huhle G; Geberth M; Hoffmann U; Heene DL; Harenberg J
    Gynecol Obstet Invest; 2000; 49(1):67-9. PubMed ID: 10629377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.
    Wester JP; Haas FJ; Biesma DH; Leusink JA; Veth G
    Intensive Care Med; 2004 Oct; 30(10):1927-34. PubMed ID: 15156309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia.
    Warkentin TE
    Dis Mon; 2005; 51(2-3):141-9. PubMed ID: 15900266
    [No Abstract]   [Full Text] [Related]  

  • 29. Dalteparin compared with an oral anticoagulant for thromboprophylaxis in patients with cancer.
    Blot E; Gutman F; Thannberger A
    N Engl J Med; 2003 Oct; 349(14):1385-7; author reply 1385-7. PubMed ID: 14523150
    [No Abstract]   [Full Text] [Related]  

  • 30. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?
    Warkentin TE; Greinacher A
    Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108
    [No Abstract]   [Full Text] [Related]  

  • 31. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
    Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
    Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.
    Kelton JG
    Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026
    [No Abstract]   [Full Text] [Related]  

  • 33. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.
    Pettilä V; Leinonen P; Markkola A; Hiilesmaa V; Kaaja R
    Thromb Haemost; 2002 Feb; 87(2):182-6. PubMed ID: 11858475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosing heparin induced thrombocytopenia in critically ill patients.
    Davies JO; Patel P; Zoumot Z
    Intensive Care Med; 2010 Aug; 36(8):1447-8. PubMed ID: 20217043
    [No Abstract]   [Full Text] [Related]  

  • 35. Dalteparin--another low-molecular-weight heparin.
    Med Lett Drugs Ther; 1995 Dec; 37(963):115-6. PubMed ID: 7500910
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic value of the 4Ts score for heparin-induced thrombocytopenia in the critically ill.
    Nagler M; Angelillo-Scherrer A
    J Crit Care; 2014 Dec; 29(6):1126-7. PubMed ID: 25113851
    [No Abstract]   [Full Text] [Related]  

  • 37. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.
    Douketis J; Cook D; Meade M; Guyatt G; Geerts W; Skrobik Y; Albert M; Granton J; Hébert P; Pagliarello G; Marshall J; Fowler R; Freitag A; Rabbat C; Anderson D; Zytaruk N; Heels-Ansdell D; Crowther M;
    Arch Intern Med; 2008 Sep; 168(16):1805-12. PubMed ID: 18779469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
    De A; Roy P; Garg VK; Pandey NK
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia?
    Levine RL; McCollum D; Hursting MJ
    Chest; 2006 Sep; 130(3):681-7. PubMed ID: 16963663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peri-operative management of heparin-induced thrombocytopenia syndrome in a patient with a suspected gynecologic malignancy.
    Burger BM; Burger A; Cromwell C; Crispens M; Fields A; Smalley ML; Boulay RM; Thomas MB; Martino MA
    Semin Oncol; 2015 Jun; 42(3):e25-31. PubMed ID: 25965371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.